Article Text

PDF
▼ Strontium ranelate discontinued

Statistics from Altmetric.com

▼ Strontium ranelate discontinued

The maker of strontium ranelate (Protelos/Osseor), Les Laboratoires Servier, will cease the distribution of the drug in August 2017.1 Strontium ranelate was granted marketing authorisation in 2004 for the treatment of severe osteoporosis in postmenopausal women and adult men who are at high risk of fracture, for whom treatment with other medicinal products approved for the treatment of osteoporosis is not possible.2 The National Institute for Health and Care Excellence guidelines …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.